pdgf-ab Search Results


recombinant pdgf ab hrpdgf ab  (R&D Systems)
94
R&D Systems recombinant pdgf ab hrpdgf ab
Recombinant Pdgf Ab Hrpdgf Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pmc01904904-121-4-14?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
recombinant pdgf ab hrpdgf ab - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
eli sa kit  (R&D Systems)
92
R&D Systems eli sa kit
Eli Sa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/us12011463-306-11-18?v=R%26D+Systems
Average 92 stars, based on 1 article reviews
eli sa kit - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
mouse rat pdgf ab quantikine elisa kit  (R&D Systems)
93
R&D Systems mouse rat pdgf ab quantikine elisa kit
Mouse Rat Pdgf Ab Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pm40615895-66-37-42?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
mouse rat pdgf ab quantikine elisa kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
mouse rat pdgf ab duoset elisa  (R&D Systems)
94
R&D Systems mouse rat pdgf ab duoset elisa
Mouse Rat Pdgf Ab Duoset Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pm37623667-67-10-18?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
mouse rat pdgf ab duoset elisa - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
human platelet derived growth factor alpha polypeptide b pdgf ab elisa kit  (Elabscience Biotechnology)
92
Elabscience Biotechnology human platelet derived growth factor alpha polypeptide b pdgf ab elisa kit
Human Platelet Derived Growth Factor Alpha Polypeptide B Pdgf Ab Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pm35282074-92-55-65?v=Elabscience+Biotechnology
Average 92 stars, based on 1 article reviews
human platelet derived growth factor alpha polypeptide b pdgf ab elisa kit - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier
immunosorbent assay elisa kit kit quantikine elisa  (R&D Systems)
94
R&D Systems immunosorbent assay elisa kit kit quantikine elisa
Immunosorbent Assay Elisa Kit Kit Quantikine Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pmc08658988-156-5-13?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
immunosorbent assay elisa kit kit quantikine elisa - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
mouse duoset elisa kits  (R&D Systems)
93
R&D Systems mouse duoset elisa kits
NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by <t>ELISA.</t> ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.
Mouse Duoset Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pmc12599120-130-11-15?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
mouse duoset elisa kits - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
recombinant rat pdgf ab heterodimer  (R&D Systems)
90
R&D Systems recombinant rat pdgf ab heterodimer
NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by <t>ELISA.</t> ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.
Recombinant Rat Pdgf Ab Heterodimer, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/pm16735540-74-5-9?v=R%26D+Systems
Average 90 stars, based on 1 article reviews
recombinant rat pdgf ab heterodimer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
quantikine elisa kits  (R&D Systems)
91
R&D Systems quantikine elisa kits
NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by <t>ELISA.</t> ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.
Quantikine Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/10__1158_slash_1078___0432__ccr___04___1201-135-25-28?v=R%26D+Systems
Average 91 stars, based on 1 article reviews
quantikine elisa kits - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier
human pdgf ab  (R&D Systems)
94
R&D Systems human pdgf ab
NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by <t>ELISA.</t> ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.
Human Pdgf Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/10__1161_slash_atvbaha__107__155754-43-1-9?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
human pdgf ab - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
quantikine mouse rat pdgf ab  (R&D Systems)
92
R&D Systems quantikine mouse rat pdgf ab
NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by <t>ELISA.</t> ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.
Quantikine Mouse Rat Pdgf Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pdgf-ab/10__4067_slash_s0716___97602012000400003-60-22-25?v=R%26D+Systems
Average 92 stars, based on 1 article reviews
quantikine mouse rat pdgf ab - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

Image Search Results


NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by ELISA. ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.

Journal: Journal for Immunotherapy of Cancer

Article Title: Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockade

doi: 10.1136/jitc-2025-012064

Figure Lengend Snippet: NDI-101150 treatment enhanced activation of primary human B cells. ( A ) Percentage of CD69 + B cells after a dose-response treatment with NDI-101150. ( B ) Percent increase in IgG production relative to DMSO in B cells after a dose-response treatment with NDI-101150. ( C ) Percent increase in B-cell proliferation on stimulation with anti-IgM and anti-CD40 after a dose-response treatment with NDI-101150. All data are graphed as the mean±SD from three human donors. ( D ) Schematic representation of the in vivo antigen-specific antibody generation study. On day 0, mice were immunized intravenously with PBS control or with antigen (Ag)—keyhole limpet hemocyanin (KLH), or dinitrophenyl (DNP)-Ficoll—followed by daily treatment with NDI-101150 from days 0 to 14. On days 7 and 14, blood was collected from mice, plasma was isolated, and Ag-specific IgM and IgG responses were determined by ELISA. ( E ) Quantification of KLH-specific IgM and IgG isotypes in blood from mice. ( F ) Quantification of DNP-specific IgM and IgG isotypes in mice. Values are mean±SD n=10 mice per treatment group. Significance was determined by one-way analysis of variance. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. QD, once daily; BIW, biweekly; DMSO, dimethylsulfoxide; ip, intraperitoneally; PBS, phosphate-buffered saline.

Article Snippet: Serum cytokines and circulating antibody titers were measured by MSD using mouse Duoset ELISA kits (R&D Systems) according to manufacturer’s instructions.

Techniques: Activation Assay, In Vivo, Control, Clinical Proteomics, Isolation, Enzyme-linked Immunosorbent Assay, Saline